company background image
2DT logo

Amneal Pharmaceuticals DB:2DT Stock Report

Last Price

€7.55

Market Cap

€2.3b

7D

4.9%

1Y

103.0%

Updated

12 Sep, 2024

Data

Company Financials +

Amneal Pharmaceuticals, Inc.

DB:2DT Stock Report

Market Cap: €2.3b

Amneal Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Amneal Pharmaceuticals
Historical stock prices
Current Share PriceUS$7.55
52 Week HighUS$7.70
52 Week LowUS$3.22
Beta1.18
11 Month Change18.90%
3 Month Change16.15%
1 Year Change102.96%
33 Year Change83.25%
5 Year Change160.70%
Change since IPO-58.99%

Recent News & Updates

Recent updates

Shareholder Returns

2DTDE PharmaceuticalsDE Market
7D4.9%-1.8%-1.5%
1Y103.0%-14.5%4.2%

Return vs Industry: 2DT exceeded the German Pharmaceuticals industry which returned -14.5% over the past year.

Return vs Market: 2DT exceeded the German Market which returned 4.2% over the past year.

Price Volatility

Is 2DT's price volatile compared to industry and market?
2DT volatility
2DT Average Weekly Movement6.5%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.7%
10% least volatile stocks in DE Market2.5%

Stable Share Price: 2DT has not had significant price volatility in the past 3 months.

Volatility Over Time: 2DT's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20027,850Chirag Patelamneal.com

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products.

Amneal Pharmaceuticals, Inc. Fundamentals Summary

How do Amneal Pharmaceuticals's earnings and revenue compare to its market cap?
2DT fundamental statistics
Market cap€2.35b
Earnings (TTM)-€158.45m
Revenue (TTM)€2.36b

1.0x

P/S Ratio

-14.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2DT income statement (TTM)
RevenueUS$2.60b
Cost of RevenueUS$1.63b
Gross ProfitUS$965.11m
Other ExpensesUS$1.14b
Earnings-US$174.62m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.56
Gross Margin37.15%
Net Profit Margin-6.72%
Debt/Equity Ratio-64,251.2%

How did 2DT perform over the long term?

See historical performance and comparison